Heme Oxygenase-1 (HO-1)

Heme Oxygenase-1 (HO-1)

Pathway Diagram

```mermaid
flowchart TD
NRF2["NRF2<br/>Transcription Factor"]
HO1_gene["HO-1 Gene<br/>HMOX1"]
HO1_protein["HO-1 Protein<br/>Heme Oxygenase-1"]

Heme["Heme<br/>Substrate"]
Bilirubin["Bilirubin<br/>Antioxidant"]
CO["Carbon Monoxide<br/>Signaling Molecule"]
Iron["Free Iron<br/>Fe2+"]

Oxidative_stress["Oxidative Stress<br/>ROS Production"]
Inflammation["Neuroinflammation<br/>Immune Response"]

Alzheimer["Alzheimer's Disease<br/>AD Pathology"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
MS["Multiple Sclerosis<br/>Demyelination"]

Neuroprotection["Neuroprotection<br/>Cell Survival"]
Ferroptosis["Ferroptosis<br/>Iron-dependent Death"]

NRF2 -->|"activates"| HO1_gene
NRF2 -->|"regulates"| HO1_protein
HO1_gene -->|"produces"| HO1_protein

HO1_protein -->|"catabolizes"| Heme
Heme -->|"breaks down to"| Bilirubin
Heme -->|"breaks down to"| CO
Heme -->|"breaks down to"| Iron

Bilirubin -->|"reduces"| Oxidative_stress
CO -->|"anti-inflammatory"| Inflammation
Iron -->|"can trigger"| Ferroptosis

HO1_protein -->|"inhibits"| Inflammation
HO1_protein -->|"promotes"| Neuroprotection

Oxidative_stress -->|"contributes to"| Alzheimer
Oxidative_stress -->|"contributes to"| ALS
Inflammation -->|"contributes to"| MS

HO1_protein -->|"therapeutic target"| Alzheimer
HO1_protein -->|"therapeutic target"| ALS
HO1_protein -->|"therapeutic target"| MS

style HO1_protein fill:#0064

Heme Oxygenase-1 (HO-1)

Pathway Diagram

Overview

Heme Oxygenase-1 (HO-1), also known as heme oxygenase (decycling) 1 (HMOX1), is a 32 kDa inducible enzyme that catalyzes the rate-limiting step in heme degradation. HO-1 degrades heme into biliverdin (subsequently converted to bilirubin), carbon monoxide (CO) — a signaling molecule, and free iron (Fe²⁺) sequestered by ferritin.

HO-1 is a critical [cytoprotective enzyme](/entities/oxidative-stress) induced by [oxidative stress](/entities/oxidative-stress), [inflammation](/entities/neuroinflammation), [hypoxia](/entities/hypoxia), and heme accumulation. It plays a vital role in [neuroprotection](/entities/neuroprotection) and is implicated in [Alzheimer's](/diseases/alzheimers-disease), [Parkinson's](/diseases/parkinsons-disease), [ALS](/diseases/als), and other neurodegenerative disorders.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">Heme Oxygenase-1 (HO-1)</th></tr>
<tr><td><b>Gene</b></td><td>[HMOX1](/genes/hmox1)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P09601](https://www.uniprot.org/uniprot/P09601)</td></tr>
<tr><td><b>PDB Structure</b></td><td>1T40, 1T41, 1T42</td></tr>
<tr><td><b>Molecular Weight</b></td><td>32,800 Da</td></tr>
<tr><td><b>Length</b></td><td>288 amino acids</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Endoplasmic reticulum (membrane)</td></tr>
<tr><td><b>Protein Family</b></td><td>Heme oxygenase family</td></tr>
</table>
</div>

Gene and Protein Structure

The HMOX1 gene is located on chromosome 5q33.1 (5q31.2-p33.1) and encodes a 288-amino acid protein. Key structural features include:

Domain Architecture

| Feature | Description |
|---------|-------------|
| N-terminal transmembrane domain | ~23 amino acids, ER membrane anchor |
| Conserved heme-binding pocket | His-25, His-82 are critical for heme binding |
| Substrate access channel | Regulates heme access to active site |
| C-terminal catalytic domain | Contains the heme degradation activity |

Enzyme Mechanism

HO-1 catalyzes heme degradation through a 3-step process consuming O₂ and NADPH:

Expression in the Brain

HO-1 is expressed in multiple cell types in the central nervous system:

• [Neurons](/entities/neurons) — particularly [dopaminergic neurons](/entities/dopaminergic-neurons) in substantia nigra
• [Astrocytes](/entities/astrocytes) — high expression in [reactive astrocytes](/entities/astrocytes)
• [Microglia](/entities/microglia) — [activated microglia](/entities/microglia) show strong induction
• [Endothelial cells](/entities/blood-brain-barrier) — BBB cells
• [Oligodendrocytes](/entities/oligodendrocytes) — myelin-producing cells

Regulation of Expression

HO-1 expression is induced by:

• Nrf2-ARE pathway: Primary transcriptional activator
• NF-κB: Pro-inflammatory induction
• Heat shock: HSF1-mediated response
• Heme: Substrate-mediated induction
• Hypoxia: HIF-1α dependent
• Glucocorticoids: Stress hormone-mediated

Normal Function

Cytoprotective Mechanisms

HO-1 provides neuroprotection through multiple mechanisms:

Iron Metabolism

The free iron released by heme degradation is highly reactive through Fenton chemistry:
Fe²⁺ + H₂O₂ → Fe³⁺ + •OH + OH⁻

However, HO-1 simultaneously induces ferritin (FTL, FTH1), which sequesters this iron safely. This coupling of heme degradation with iron sequestration is essential for neuroprotection.

CO Signaling

Carbon monoxide acts as a signaling molecule through:

• Soluble guanylate cyclase (sGC): Activates cGMP production
• p38 MAPK pathway: Anti-apoptotic signaling
• NF-κB inhibition: Anti-inflammatory effects
• Mitochondrial dynamics: Regulates fission/fusion

Role in Neurodegeneration

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), HO-1 exhibits complex regulation:

• Upregulation in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
• Colocalization with [amyloid-beta](/proteins/amyloid-beta) plaques
• Interaction with [heme toxicity](/entities/heme) in neurodegeneration
• Dual role: Both protective and potentially detrimental

• Neurons surrounding plaques
• Reactive astrocytes
• Microvascular endothelial cells

• Response to oxidative stress from Aβ
• Iron dysregulation in AD brain
• [Neuroinflammation](/mechanisms/neuroinflammation)driven induction

Parkinson's Disease

HO-1 is strongly induced in [Parkinson's disease](/diseases/parkinsons-disease):

• [Substantia nigra](/cell-types/substantia-nigra-compacta-neurons) dopaminergic neurons
• [Microglial](/entities/microglia) cells surrounding neurons
• Reactive astrocytes

• LRRK2 G2019S mutation increases HO-1 induction
• HO-1 polymorphisms affect PD risk
• Dopamine metabolism generates oxidative stress

• Hemin (HO-1 inducer) protects dopaminergic neurons
• CO-releasing molecules (CORMs) show promise

Amyotrophic Lateral Sclerosis

In [ALS](/diseases/amyotrophic-lateral-sclerosis):

• HO-1 upregulation in motor neurons
• Response to SOD1 mutations
• Astrocyte involvement

Signaling Pathways

Transcriptional Regulation

HO-1 regulation:
├── [Nrf2](/entities/nrf2) → ARE-mediated transcriptional activation
├── [NF-κB](/entities/nf-kappa-b) → Pro-inflammatory suppression
├── [MAPK pathways](/proteins/mapk1-protein) → Stress response kinase cascades
└── [p38 signaling](/proteins/mapk14-protein) → Cell survival signaling

HO-1 products:
├── Biliverdin → Bilirubin (antioxidant)
├── CO → cGMP signaling (anti-apoptotic, anti-inflammatory)
└── Fe²⁺ → Ferritin sequestration (prevents Fenton chemistry)

Downstream Effects

| HO-1 Product | Primary Effect | Neuroprotective Mechanism |
|--------------|---------------|----------------------------|
| Biliverdin | Antioxidant | Scavenges peroxyl radicals |
| Bilirubin | Antioxidant | Neutralizes peroxynitrite |
| CO | Signaling | Anti-apoptotic, anti-inflammatory |
| Fe²⁺ | Ferritin induction | Prevents iron-mediated ROS |

Therapeutic Targeting

HO-1 Inducers (Upregulate Expression)

| Compound | Mechanism | Status | Reference |
|----------|-----------|--------|-----------|
| Hemin | Nrf2 activation | Clinical | [@barone2011] |
| Curcumin | Nrf2 activation | Preclinical | — |
| Statins | MEK/ERK dependent | Clinical | — |
| CBD (cannabidiol) | VDR/Nrf2 dependent | Phase 2 | — |
| Sulforaphane | KEAP1-Nrf2 | Phase 1 | — |

HO-1 Inhibitors (Block Activity)

| Compound | Mechanism | Status |
|----------|-----------|--------|
| Tin protoporphyrin IX | Competitive inhibitor | Research |
| Zinc protoporphyrin IX | Competitive inhibitor | Research |
| Pegylated Zinc PP-IX | Improved delivery | Preclinical |

Gene Therapy Approaches

• AAV-HMOX1: Gene therapy for overexpression
• Cell-penetrating CO-releasing molecules (CORMs): Mimic CO signaling
• Biliverdin supplementation: Bypass HO-1 for antioxidant effects

Clinical Trials

| Trial | Compound | Phase | Status | Disease |
|-------|----------|-------|--------|---------|
| NCT01716594 | Hemin | Phase 2 | Completed | Acute brain injury |
| NCT03729768 | Hemin | Phase 1 | Recruiting | PD |
| NCT04561072 | CDDO-Im | Phase 2 | Active | AD |

[@chen2024]

Genetic Associations

HMOX1 Polymorphisms

| SNP | Effect | Disease Association |
|-----|-------|---------------------|
| rs2071746 (promoter) | Altered HO-1 expression | PD risk |
| rs2071747 | Modified oxidative stress response | AD risk |
| rs5995178 | Altered promoter activity | ALS risk |

Biomarkers

• Serum HO-1: Elevated in neurodegenerative disease
• CSF HO-1: Correlates with disease progression
• HO-1 activity: Post-mortem brain tissue

Animal Models

| Model | Application | Reference |
|-------|-------------|-----------|
| Hmox1-/- mice | HO-1 knockout | Lethal (embryonic) |
| Hmox1+/- mice | Haploinsufficiency | Oxidative stress sensitive |
| TG-HMOX1 | Neuron-specific overexpression | Protected in PD/AD models |

Cross-Linking

Related Proteins

• [HMOX1 Gene](/genes/hmox1) — Encoding gene
• [Nrf2](/proteins/nrf2-protein) — Transcriptional regulator
• [Ferritin](/proteins/ferritin-protein) — Iron sequestration
• [Biliverdin reductase](/proteins/bvrd-protein) — Biliverdin → Bilirubin

Related Mechanisms

• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Iron Homeostasis](/mechanisms/iron-homeostasis)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pathway)

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)
• [Huntington's Disease](/diseases/huntingtons)

See Also

• [HMOX1 Gene](/genes/hmox1)
• [Nrf2 Signaling](/entities/nrf2)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Iron Homeostasis](/mechanisms/iron-homeostasis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)

External Links

• [UniProt: P09601](https://www.uniprot.org/uniprot/P09601)
• [NCBI Gene: 3162](https://www.ncbi.nlm.nih.gov/gene/3162)
• [KEGG Pathway: heme degradation](https://www.genome.jp/pathway/map00860)
• [HO-1 Database](https://www.hemoxygenase.org/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Heme Oxygenase-1 (HO-1) discovered through SciDEX knowledge graph analysis: